
Get started
Sign in
Close

Research

Featured research

Extracting seizure frequency at scale using the Truveta Language Model

Extracting seizure frequency from clinical notes at scale using the Truveta Language Model

Seizure frequency is one of the most important outcomes in epilepsy research, but it often lives in unstructured clinical notes rather than standard EHR fields. In a recent Neurology abstract, researchers from SK Life Science and Truveta show how the Truveta Language...
Read More
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through February 2026 

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through February 2026 

Respiratory virus-associated hospitalizations declined slightly in February 2026 to 3.6% of all hospitalizations. Among children aged 0-4 years, respiratory virus-associated hospitalizations increased slightly to 4.3% of all hospitalizations, with the increase driven...
Read More
CDC publishes national COVID-19 analysis using Truveta Data in the MMWR

CDC publishes national COVID-19 analysis using Truveta Data

Older adults remain at highest risk for COVID-19–related hospitalization. Yet a new CDC analysis suggests that effective antiviral treatments are likely underprescribed among outpatients aged 65 or older, with prescribing patterns varying alongside disease...
Read More
Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval – Truveta research report cover image.

Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval

A large proportion of early users (36.1%) of oral semaglutide (Wegovy pill) had no prior evidence of GLP-1-based medication use, suggesting rapid uptake among patients new to taking GLP-1 medications. Among patients who previously used a GLP-1-based medication, most...
Read More

Featured research topics

GLP-1

Oncology

Flu/RSV

Measles

Cardiovascular